Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M. White, Adolfo García‐Sastre, Romel Rosales et al.|Science|2021Cited by 364
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesisThomas Kehrer, Lisa Miorin|Cell Host & Microbe|2023Cited by 74
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Michael Schotsaert, Soner Yildiz et al.|Nature Communications|2022Cited by 41
Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injuryNanditha Anandakrishnan, Evren U. Azeloglu, Zhengzi Yi et al.|medRxiv|2024Cited by 0